ArticleJournal of robotic surgery2026
Retzius-sparing robotic radical prostatectomy: Insights and outcomes from the UAE experience.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the application of Retzius-Sparing Robotic Radical Prostatectomy (RS-RRP) in the UAE healthcare system, focusing on patient outcomes, continence recovery, and oncological efficacy. This retrospective cohort study analyzed 100 patients who underwent RS-RRP at Clemenceau Medical Center Hospital in Dubai between June 2021 and December 2024. Data collected included demographics, intraoperative metrics, postoperative recovery, and oncological outcomes. Ethical approval was obtained from the institutional review board. The median age of patients was 60 years, with most presenting intermediate-risk prostate cancer. The median console time was 94 minutes, and blood loss was minimal (median: 100 mL). Postoperatively, 78 % of patients achieved immediate continence, rising to 97% during follow-up. The positive margin rate was 27%, with apical margins in 40% of cases. Pathological staging revealed pT2 in 61% and advanced disease in 39% of patients. Minor complications occurred in a few cases, with no intraoperative complications reported. RS-RRP is a feasible and effective approach for managing prostate cancer in the UAE. The study highlights favourable functional and oncological outcomes, comparable to international benchmarks, underscoring its potential as a standard technique in high-volume centers.
Indexed as
Identifiers
41920488What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.